1. Introduction
===============

Chiral β-amino acid ester derivatives exhibit diverse biological properties such as antitumor, immunostimulating, and antiphlogistic activities \[[@B1-molecules-19-03955],[@B2-molecules-19-03955],[@B3-molecules-19-03955],[@B4-molecules-19-03955]\]. They have been widely used as peptidomimetics and are found in many natural products. β-Lactams, which exhibit a wide range of biological properties such as antibiotic, antiviral, and protease inhibitor activities. Penicillin ([Figure 1](#molecules-19-03955-f001){ref-type="fig"}), the first antibiotic, has saved more than 50 million people's life \[[@B5-molecules-19-03955],[@B6-molecules-19-03955],[@B7-molecules-19-03955],[@B8-molecules-19-03955],[@B9-molecules-19-03955]\]. Cephalosporins and carbapenems ([Figure 1](#molecules-19-03955-f001){ref-type="fig"}) exhibit a broad spectrum of antibacterial activity. β-Amino acid ester derivatives can be used as building blocks for the synthesis of these types of antibiotics, making them useful in drug synthesis and other fields \[[@B10-molecules-19-03955],[@B11-molecules-19-03955],[@B12-molecules-19-03955],[@B13-molecules-19-03955]\].

![Penicillins, cephalosporins and carbapenems.](molecules-19-03955-g001){#molecules-19-03955-f001}

The asymmetric synthesis of β-amino ester derivatives or β-lactams has received much attention in organic synthesis over the past few years \[[@B3-molecules-19-03955],[@B14-molecules-19-03955]\]. In 2011, Bull and coworkers reported the first example of an intramolecular cyclization of the ester enolate imine for the preparation of monocyclic β-lactams ([Figure 2](#molecules-19-03955-f002){ref-type="fig"}) \[[@B15-molecules-19-03955]\].

![β-lactams and β-amino esters.](molecules-19-03955-g002){#molecules-19-03955-f002}

The asymmetric Mannich reaction is one of the most general methods for the preparation of β-amino acid ester derivatives \[[@B16-molecules-19-03955],[@B17-molecules-19-03955],[@B18-molecules-19-03955],[@B19-molecules-19-03955],[@B20-molecules-19-03955],[@B21-molecules-19-03955],[@B22-molecules-19-03955]\]. However, only simple aldehydes and amines have been used as Mannich reaction substrates. Numerous methods have been developed for improving its application \[[@B23-molecules-19-03955],[@B24-molecules-19-03955],[@B25-molecules-19-03955],[@B26-molecules-19-03955],[@B27-molecules-19-03955],[@B28-molecules-19-03955],[@B29-molecules-19-03955],[@B30-molecules-19-03955],[@B31-molecules-19-03955],[@B32-molecules-19-03955],[@B33-molecules-19-03955],[@B34-molecules-19-03955],[@B35-molecules-19-03955],[@B36-molecules-19-03955],[@B37-molecules-19-03955]\], but imine substrates prepared from heteroaryl aldehydes were rarely reported.

Benzothiazoles have varied biological activities \[[@B38-molecules-19-03955],[@B39-molecules-19-03955],[@B40-molecules-19-03955]\]. They are widely found in bioorganic and medicinal chemistry with applications in drug discovery and are still of great scientific interest nowadays \[[@B41-molecules-19-03955]\]. Benzothiazole moieties are part of compounds showing numerous biological activities such as antibacterial, antimicrobial, anthelmintic, antitumor, anti-inflammatory properties \[[@B42-molecules-19-03955],[@B43-molecules-19-03955]\].

Recently, we independently reported a chiral cinchona alkaloid-derived thiourea catalyst for enantioselective synthesis of chiral β-amino esters by Mannich-type reaction \[[@B44-molecules-19-03955],[@B45-molecules-19-03955],[@B46-molecules-19-03955],[@B47-molecules-19-03955]\]. Herein, we report an extension of our previous study by using potentially bioactive benzothiophene and benzothiazole moieties \[[@B48-molecules-19-03955],[@B49-molecules-19-03955],[@B50-molecules-19-03955]\] as the building blocks for the synthesis of chiral β-amino acid ester derivatives. The structures of these newly synthesized compounds were confirmed by ^1^H-NMR, ^13^C-NMR, IR spectra, and MS (HREI) analysis. The desired products **5a**--**5p** were obtained in good yields and high enantioselectivities (\~86% yield, \>99% ee) according to the optimized reaction conditions. Bioassays identified these newly compounds possessing weak to good antifungal activity. The inhibition rate of **5dr** (we used the postfixes "r" and "c" to distinguish between racemic and chiral compounds) against *F*. *oxysporum* was 60.53%, higher than the commercial agricultural fungicide *hymexazol* whose inhibition rate was 56.12%. Further experimental and mechanism of antifungal activity are underway.

2. Results and Discussion
=========================

2.1. Optimization of Reaction Conditions
----------------------------------------

The general synthetic strategy for the preparation of imines by reaction of aldehydes with amino benzothiophene derivatives is outlined in [Scheme 1](#molecules-19-03955-f004){ref-type="scheme"}. All products **3a**--**d** were characterized by spectroscopic methods.

![Synthesis of imines **3a**--**d**.](molecules-19-03955-g004){#molecules-19-03955-f004}

Then, synthetically designed cinchona alkaloid thiourea **Q** ([Figure 3](#molecules-19-03955-f003){ref-type="fig"}) was used as the catalyst for asymmetric catalytic Mannich-type reaction of the imines and malonate ester. Catalyst **Q** bearing strong electron-withdrawing trifluoromethyl substituent on the benzene ring exhibited excellent catalytic activity because of its ability to promote the reaction through intermolecular hydrogen bond activation of the substrates. The effect of the reaction temperature, solvent, and catalyst loading was evaluated using catalyst **Q** ([Table 1](#molecules-19-03955-t001){ref-type="table"}). Temperature had a pronounced effect on yield and enantioselectivity of the reactions. Use of other solvents, such as THF, acetone, and toluene, resulted in lower enatioselectivities compared to the use of dichloromethane (DCM) ([Table 1](#molecules-19-03955-t001){ref-type="table"}, entries 1--5). The best result was achieved at room temperature using 10 mol% of catalyst **Q** in DCM.

![Structure of the cinchona alkaloid-derived thiourea catalyst.](molecules-19-03955-g003){#molecules-19-03955-f003}

molecules-19-03955-t001_Table 1

###### 

Optimization of reaction conditions using catalyst **Q**.

![](molecules-19-03955-i001.jpg)

  Entry   Temperature (°C)   Solvent   Catalyst (mol%)   Time (h)   Yield ^a^ (%)   ee ^b^ (%)
  ------- ------------------ --------- ----------------- ---------- --------------- ------------
  1       r.t.               THF       10                72         34              30
  2       Reflux             THF       10                2          \-              \-
  3       r.t.               PhMe      10                72         52              34
  4       Reflux             PhMe      10                12         54              26
  5       r.t.               Acetone   10                72         38              20
  6       r.t.               DCM       10                72         61              78
  7       35                 DCM       10                24         67              56
  8       r.t.               DCM       5                 96         48              76
  9       r.t.               DCM       20                72         72              78

^a^ Isolated yields after chromatographic purification; ^b^ Determined by HPLC analysis using Chiralpak IA.

Under the optimized reaction conditions, the synthetic scope of the reaction was investigated using different imines and malonate esters, and the results are listed in [Table 2](#molecules-19-03955-t002){ref-type="table"}.

molecules-19-03955-t002_Table 2

###### 

Enantioselective Mannich-type reaction of imines and malonate esters.

![](molecules-19-03955-i002.jpg)

  Entry   Products   R          R^1^             Time (h) ^a^   Yield (%) ^b^   ee (%) ^c^
  ------- ---------- ---------- ---------------- -------------- --------------- ------------
  1       **5ac**    6-H        −CH~3~           72             82              56
  2       **5bc**    6-H        −C~2~H~5~        72             80              80
  3       **5cc**    6-H        −C~3~H~7~        96             78              76
  4       **5dc**    6-H        −CH~2~C~6~H~5~   96             76              92
  5       **5ec**    6-Cl       −CH~3~           72             85              64
  6       **5fc**    6-Cl       −C~2~H~5~        72             86              82
  7       **5gc**    6-Cl       −C~3~H~7~        96             82              80
  8       **5hc**    6-Cl       −CH~2~C~6~H~5~   96             78              \>99
  9       **5ic**    6-OCH~3~   −CH~3~           72             81              80
  10      **5jc**    6-OCH~3~   −C~2~H~5~        72             80              80
  11      **5kc**    6-OCH~3~   −C~3~H~7~        96             79              70
  12      **5lc**    6-OCH~3~   −CH~2~C~6~H~5~   96             75              89
  13      **5mc**    6-CH~3~    −CH~3~           72             81              78
  14      **5nc**    6-CH~3~    −C~2~H~5~        72             76              76
  15      **5oc**    6-CH~3~    −C~3~H~7~        96             76              80
  16      **5pc**    6-CH~3~    −CH~2~C~6~H~5~   96             72              86

^a^ Reactions were performed using imine (0.50 mmol) and malonate ester (0.60 mmol) in DCM (3 mL) in the presence of 10 mol% catalyst **Q** at room temperature for 72--96 h; ^b^ Isolated yield after chromatographic purification; ^c^ Determined by HPLC analysis using Chiralpak IA.

The desired products **5a**--**p** were obtained in good yields and high enantioselectivities (\~86% yield, \>99% ee) using to the optimized reaction conditions. In addition, the enantioselectivity of **5dc**, **5hc**, **5lc** and **5pc** was higher than that of the other compounds, probably because of malonate ester was a benzyl ester, and steric hindrance affected the Mannich-type reaction between imines and benzyl esters.

2.2. Antifungal Activity
------------------------

The antifungal activity of compounds **5** was assayed by the reported method \[[@B51-molecules-19-03955],[@B52-molecules-19-03955]\]. As it can be seen from the results presented in [Table 3](#molecules-19-03955-t003){ref-type="table"}, compound **5dr** possess medium antifungal activity against *G*. *zeae*, *C*. *mandshurica* and *F*. *oxysporum*, with inhibition rates of 40.67%, 41.44% and 60.53%, respectively.

molecules-19-03955-t003_Table 3

###### 

Fungicidal activity of the compounds **5ar**--**pr** at a concentration of 50 μg/mL.

  Entry   Compound             Inhibition rate ^a^ *(%)*                                                            
  ------- -------------------- --------------------------- ------------- ------------- -------------- ------------- --------------
  1       **5dr**              16.00 ± 0.1                 9.76 ± 0.5    47.04 ± 1.1   38.16 ± 1.84   13.06 ± 1.5   37.42 ± 0.62
  2       **5br**              11.67 ± 0.4                 10.18 ± 0.7   37.17 ± 1.1   30.04 ± 2.31   9.70 ± 0.8    21.29 ± 0.76
  3       **5cr**              6.03 ± 0.7                  10.18 ± 0.8   19.74 ± 1.5   18.37 ± 1.18   4.1 ± 0.7     3.33 ± 0.5
  4       **5dr**              40.67 ± 0.9                 41.44 ± 0.7   60.53 ± 2.2   10.11 ± 1.22   1.12 ± 0.7    6.67 ± 0.6
  5       **5er**              3.33 ± 0.5                  11.66 ± 0.5   25.99 ± 1.1   16.01 ± 2.31   2.33 ± 0.8    3.20 ± 0.4
  6       **5fr**              8.67 ± 0.5                  16.45 ± 0.7   30.59 ± 0.7   18.37 ± 1.23   2.33 ± 0.8    2.30 ± 1.3
  7       **5gr**              4.20 ± 0.5                  13.13 ± 1.1   16.78 ± 2.3   9.80 ± 0.69    1.03 ± 0.8    5.67 ± 0.8
  8       **5hr**              6.30 ± 0.7                  11.66 ± 1.6   13.82 ± 2.3   13.18 ± 1.26   3.33 ± 0.5    3.33 ± 0.5
  9       **5ir**              9.67 ± 0.9                  18.97 ± 1.0   42.76 ± 2.6   11.21 ± 2.10   6.67 ± 0.6    21.29 ± 0.76
  10      **5jr**              11.67 ± 0.6                 12.71 ± 1.0   16.78 ± 1.7   13.07 ± 0.84   3.20 ± 0.4    3.33 ± 0.5
  11      **5kr**              4.67 ± 0.7                  11.23 ± 1.2   16.45 ± 1.5   15.90 ± 1.24   2.30 ± 1.3    6.67 ± 0.6
  12      **5lr**              0.67 ± 0.6                  17.18 ± 1.1   10.53 ± 2.1   3.33 ± 0.5     5.67 ± 0.8    3.20 ± 0.4
  13      **5mr**              1.02 ± 0.7                  10.87 ± 0.8   10.86 ± 1.2   6.67 ± 0.6     3.33 ± 0.5    2.30 ± 1.3
  14      **5nr**              4.33 ± 0.8                  10.50 ± 0.8   14.14 ± 0.5   3.20 ± 0.4     6.67 ± 0.6    5.67 ± 0.8
  15      **5or**              4.33 ± 0.8                  19.36 ± 1.5   14.14 ± 1.9   2.30 ± 1.3     3.20 ± 0.4    3.33 ± 0.5
  16      **5pr**              3.33 ± 0.8                  19.39 ± 0.3   29.93 ± 1.0   5.67 ± 0.8     2.30 ± 1.3    6.67 ± 0.6
  17      **Hymexazole ^b^**   55.54 ± 3.9                 49.61 ± 7.8   56.12 ± 4.1   51.21 ± 5.9    68.22 ± 2.4   77.51 ± 3.9
  18      **DMSO**             0                           0             0             0              0             0

^a^ Average of five replicates; ^b^ The commercial agricultural fungicide hymexazole was used for comparison of antifungal activity.

3. Experimental
===============

3.1. Instruments and Chemicals
------------------------------

Melting points were determined using a XT-4 binocular microscope (Beijing Tech Instrument Co., Beijing, China) and were not corrected. IR spectra were recorded using a Bruker VECTOR 22 spectrometer in KBr disks. ^1^H- and ^13^C-NMR spectra were recorded using a JEOL-ECX 500 MHz NMR spectrometer at room temperature in CDCl~3~ or DMSO-d~6~ solvent using tetrametylsilane as the internal standard. Elemental analyses were performed using an Elementar Vario-III CHN analyzer. MS spectra were recorded using a VG Autospec-3000 spectrometer. Analytical TLC was performed using silica gel GF254 plates. Column chromatographic purifications were carried out using column chromatographic silica gel. All the reagents were purchased from commercial sources and used as received, unless otherwise noted. Reactions were performed under a positive dry argon pressure in oven-dried or flame-dried glassware equipped with a magnetic stir bar. Standard inert atmosphere techniques were used in handling all air and moisture sensitive reagents. All the reagents were of analytical reagent grade or in chemically pure form. All the solvents were dried, deoxygenated, and distilled prior to use.

3.2. Synthesis
--------------

### 3.2.1. General Methods for Preparation of **3a**--**d**

6-Substituted-2-aminobenzothiazole (10 mmol) was dissolved in toluene (10 mL), and the resulting solution was magnetically stirred, followed by dropwise addition of benzothiophene-2-methanal (10 mmol) dissolved in toluene (10 mL) at room temperature. The resulting reaction mixture was refluxed after adding acetic acid (1.0 mL), and complete consumption of the starting materials was observed after 24 h. After the completion of the reaction, the solvent was removed by distillation under reduced pressure. The resulting residue was recrystallized using ethyl alcohol to afford products **3a**--**3d**.

### 3.2.2. Characterization of **3a**--**d**

*N-(Benzo\[b\]thiophen-2-ylmethylene)benzo\[d\]thiazol-2-amine* (**3a**). Yellow solid; mp: 216−218 °C; yield: 78%; ^1^H-NMR (DMSO-*d*~6~) δ (ppm): 9.50--9.49 (m, 1H, 11-C[H]{.ul}), 8.37-8.36 (m, 1H, 9-C[H]{.ul}), 8.05--8.00 (m, 2H, 6-C[H]{.ul}, 17-C[H]{.ul}), 7.92--7.90 (m, 2H, 7-C[H]{.ul}, 8-C[H]{.ul}), 7.51--7.47 (m, 2H, 20-C[H]{.ul}, 14-C[H]{.ul}), 7.46--7.40 (m, 2H, 18-C[H]{.ul}, 19-C[H]{.ul}); ^13^C-NMR (DMSO-*d*~6~) δ (ppm): 171.1 (2-[C]{.ul}), 161.5 (16-[C]{.ul}), 151.8 (4-[C]{.ul}), 142.2 (11-[C]{.ul}), 141.2 (12-[C]{.ul}), 139.6 (5-[C]{.ul}), 136.5 (15-[C]{.ul}), 134.8 (8-[C]{.ul}), 128.6 (7-[C]{.ul}), 127.3 (19-[C]{.ul}), 126.5 (18-[C]{.ul}), 125.9 (6-[C]{.ul}), 125.5 (9-[C]{.ul}), 123.7 (17-[C]{.ul}), 123.2 (20-[C]{.ul}), 122.3 (14-[C]{.ul}); IR (KBr, cm^−1^) ν: 3051, 3022, 1587, 1558, 1456, 1417, 1149, 1120, 820, 723; MS (ESI): *m/z* = 295 \[M+H\]^+^, 317 \[M+Na\]^+^.

*N-(Benzo\[b\]thiophen-2-ylmethylene)-6-chlorobenzo\[d\]thiazol-2-amine* (**3b**). Yellow solid; mp: 229−231 °C; yield: 82%; ^1^H-NMR (DMSO-*d*~6~) δ (ppm): 9.47 (s, 1H, 6-C[H]{.ul}), 8.37 (s, 1H, 11-C[H]{.ul}), 8.23 (d, 1H, *J* = 5 Hz, 17-C[H]{.ul}), 8.07--8.02 (m, 2H, 9-C[H]{.ul}, 8-C[H]{.ul}), 7.91(d, 1H, *J* = 10 Hz, 20-C[H]{.ul}), 7.54--7.51 (m, 2H, 18-C[H]{.ul}, 19-C[H]{.ul}), 7.47--7.44 (m, 1H, 14-C[H]{.ul}); ^13^C-NMR (DMSO-*d*~6~) δ (ppm): 162.1 (2-[C]{.ul}), 150.6 (16-[C]{.ul}), 142.1 (4-[C]{.ul}), 141.1 (11-[C]{.ul}), 139.6 (6-[C]{.ul}), 136.8 (12-[C]{.ul}), 136.2 (5-[C]{.ul}), 130.2 (15-[C]{.ul}), 128.7 (8-[C]{.ul}), 127.8 (7-[C]{.ul}), 126.5 (19-[C]{.ul}), 126.0 (18-[C]{.ul}), 125.4 (9-[C]{.ul}), 124.4 (17-[C]{.ul}), 123.8 (20-[C]{.ul}), 122,7 (14-[C]{.ul}); IR (KBr, cm^−1^) ν: 3053, 2843, 1600, 1564, 1479, 1174, 1143, 1126, 810, 748; MS (ESI): *m/z* = 329 \[M+H\]^+^, 351 \[M+Na\]^+^.

*N-(Benzo\[b\]thiophen-2-ylmethylene)-6-methoxybenzo\[d\]thiazol-2-amine* (**3c**). Yellow solid; mp: 181--183 °C; yield: 78%; ^1^H-NMR (DMSO-*d*~6~) δ (ppm): 9.44--9.43 (s, 1H, 11-C[H]{.ul}), 8.35 (s, 1H, 17-C[H]{.ul}), 8.09 (d, 1H, *J* = 5 Hz, 6-C[H]{.ul}), 8.04 (d, 1H, *J* = 10 Hz, 8-C[H]{.ul}), 7.85(d, 1H, *J* = 20 Hz, 9-C[H]{.ul}), 7.68 (s, 1H, 20-C[H]{.ul}), 7.56(t, 1H, *J* = 30 Hz, 19-C[H]{.ul}), 7.49 (t, 1H, *J* = 30 Hz, 14-C[H]{.ul}), 7.14--7.12 (m, 1H, 18-C[H]{.ul}), 3.85 (s, 3H, 22-C-OC[H~3~]{.ul}); ^13^C-NMR (DMSO-*d*~6~) δ (ppm): 168.5 (2-[C]{.ul}), 160.3 (16-[C]{.ul}), 158.0 (4-[C]{.ul}), 146.1 (11-[C]{.ul}), 141.8 (6-[C]{.ul}), 141.4 (12-[C]{.ul}), 139.6 (5-[C]{.ul}), 136.2 (15-[C]{.ul}), 135.8 (8-[C]{.ul}), 128.4 (7-[C]{.ul}), 126.3 (19-[C]{.ul}), 125.9 (18-[C]{.ul}), 123.9 (9-[C]{.ul}), 123.7 (17-[C]{.ul}), 116.6 (20-[C]{.ul}), 105.6 (14-[C]{.ul}), 56.3 (22-[C]{.ul}); IR (KBr, cm^−1^) ν: 3055, 2843, 1598, 1570, 1477, 1458, 1425, 1265, 1224, 1126, 1118, 1053, 1018, 833, 746; MS (ESI): *m/z* = 325 \[M+H\]^+^, 347 \[M+Na\]^+^.

*N-(Benzo\[b\]thiophen-2-ylmethylene)-6-methylbenzo\[d\]thiazol-2-amine* (**3d**). Yellow solid; mp: 221--222 °C; yield: 78%; ^1^H-NMR (DMSO-*d*~6~) δ (ppm): 9.44 (d, 1H, *J* = 10 Hz, 11-C[H]{.ul}), 8.33 (d, 1H, *J* = 10 Hz, 6-C[H]{.ul}), 8.06--8.01 (m, 2H, 9-C[H]{.ul}, 17-C[H]{.ul}), 7.84--7.78 (m, 2H, 18-C[H]{.ul}, 19-C[H]{.ul}), 7.47--7.44 (m, 2H, 14-C[H]{.ul}, 20-C[H]{.ul}), 7.32(d, 1H, *J* = 10Hz, 8-C[H]{.ul}), 2.46 (s, 3H, 21-C[H~3~]{.ul}); ^13^C-NMR (DMSO-*d*~6~) δ (ppm): 170.0 (2-[C]{.ul}), 160.9 (16-[C]{.ul}), 149.8 (4-[C]{.ul}), 141.9 (11-[C]{.ul}), 141.3 (6-[C]{.ul}), 139.6 (12-[C]{.ul}), 136.2 (5-[C]{.ul}), 135.8 (15-[C]{.ul}), 134.8 (8-[C]{.ul}), 128.7 (7-[C]{.ul}), 128.5 (19-[C]{.ul}), 126.4 (18-[C]{.ul}), 125.9 (9-[C]{.ul}), 123.7 (17-[C]{.ul}), 122.8 (20-[C]{.ul}), 122.5 (14-[C]{.ul}), 21.7 (22-[C]{.ul}); IR (KBr, cm^−1^) ν: 3045, 2845, 1573, 1539, 1471, 1427, 1346, 1118, 819, 744; MS (ESI): *m/z* = 309 \[M+H\]^+^, 331 \[M+Na\]^+^.

### 3.2.3. General Method for the Preparation of **5a**--**p**

To a magnetically stirred solution of imine (0.50 mmol) in DCM (3 mL) in the presence of 10% catalyst **Q**, the malonate ester (0.7 mmol) was added dropwise at room temperature. The complete consumption of starting materials was observed after 72--96 h. After removing the solvent by reduced pressure distillation, the reaction mixture was subjected to column chromatography on silica gel (EA/PE = 1:7) to afford compounds **5a**--**p**.

### 3.2.4. Characterization of **5a**--**p**

*Dimethyl 2-(benzo\[b\]thiophen-2-yl(benzo\[d\]thiazol-2-ylamino)methyl)malonate* (**5ar**). White solid; mp: 123--125 °C; yield: 82%; ^1^H-NMR (CDCl~3~): δ (ppm) 7.74 (d, 1H, *J* = 10 Hz, 24-C[H]{.ul}), 7.68 (d, 1H, *J* = 10 Hz, 27-C[H]{.ul}), 7.57 (t, 2H, *J* = 15 Hz, 14-C[H]{.ul}, 17-C[H]{.ul}), 7.31--7.25 (m, 4H, 25-C[H]{.ul}, 26-C[H]{.ul}, 15-C[H]{.ul}, 16-C[H]{.ul}), 7.10 (t, 1H, *J* = 15 Hz, 11-C[H]{.ul}), 7.00 (s, 1H, N[H]{.ul}), 6.14 (d, 1H, *J* = 5 Hz, 8-C[H]{.ul}), 4.21 (d, 1H, *J* = 5 Hz, 2-C[H]{.ul}), 3.73 (s, 6H, 28-C[H~3~]{.ul}, 29-C[H~3~]{.ul}); ^13^C-NMR (CDCl~3~): δ (ppm) 168.5 (20-[C]{.ul}), 166.9 (1-[C]{.ul}), 165.7 (3-[C]{.ul}), 152.1 (10-[C]{.ul}), 143.1 (13-[C]{.ul}), 139.5 (22-[C]{.ul}), 139.4 (23-[C]{.ul}), 131.0 (12-[C]{.ul}), 126.0 (15-[C]{.ul}), 124.7 (16-[C]{.ul}), 124.6 (25-[C]{.ul}), 123.8 (26-[C]{.ul}), 122.4 (24-[C]{.ul}), 122.2 (27-[C]{.ul}), 122.1 (14-[C]{.ul}), 120.9 (17-[C]{.ul}), 119.7 (11-[C]{.ul}), 56.4 (8-[C]{.ul}), 54.7 (2-[C]{.ul}), 53.4 (28-[C]{.ul}), 53.2 (29-[C]{.ul}); MS (ESI): *m/z* = 427 \[M+H\]^+^, 449 \[M+Na\]^+^; MS (HREI): C~21~H~18~N~2~O~4~S~2~ Na for +, calculated 426.0708, found 426.0708; IR (KBr, cm^−1^) ν 3367, 2954, 1747, 1743, 1533, 1361, 1157, 1039, 842, 763, 723.

*(+) Dimethyl 2-(benzo\[b\]thiophen-2-yl(benzo\[d\]thiazol-2-ylamino)methyl)malonate* (**5ac**). This product was obtained as a white solid from a reaction catalyzed by **Q** (10 mol%) at 25 °C for 72 h; mp: 123--125 °C; yield: 81% after preparative column chromatography purification (silica gel, PE/ethyl ether = 7/1); 56.0% ee as determined by HPLC \[Daicel Chiralpak IA, hexane/EtOH = 75/25, 1.0 mL/min, λ = 254 nm, tr (major) = 12.74 min, tr (minor) = 11.66 min\]; ![](molecules-19-03955-i003.jpg) = +75.36 (c = 0.069 g/100 mL, CHCl~3~).

*Diethyl 2-(benzo\[b\]thiophen-2-yl(benzo\[d\]thiazol-2-ylamino)methyl)malonate* (**5br**). White solid; mp: 93--95 °C; yield: 83%; ^1^H-NMR (CDCl~3~)δ (ppm): 7.74 (d, 1H, *J* = 10 Hz, 24-C[H]{.ul}), 7.68 (d, 1H, *J* = 10 Hz, 27-C[H]{.ul}), 7.57 (t, 2H, *J* = 15Hz, 14-C[H]{.ul}, 17-C[H]{.ul}), 7.29-7.27 (m, 4H, 25-C[H]{.ul}, 26-C[H]{.ul}, 15-C[H]{.ul}, 16-C[H]{.ul}), 7.09 (t, 1H, *J* = 15 Hz, 11-C[H]{.ul}), 7.04 (s, 1H, N[H]{.ul}), 6.15 (d, 1H, *J* = 5Hz, 8-C[H]{.ul}), 4.24 (d, 1H, *J* = 5Hz, 2-C[H]{.ul}), 4.19--4.15 (m, 4H, 28-C[H~2~]{.ul}, 29-C[H~2~]{.ul}), 1.22--1.16 (m, 6H, 30-C[H~3~]{.ul}, 31-C[H~3~]{.ul}); ^13^C-NMR (CDCl~3~) δ (ppm): 168.1 (20-[C]{.ul}), 166.6 (1-[C]{.ul}), 165.8 (3-[C]{.ul}), 152.2 (100-[C]{.ul}), 143.3 (13-[C]{.ul}), 139.5 (22-[C]{.ul}), 131.0 (23-[C]{.ul}), 126.0 (12-[C]{.ul}), 124.8 (15-[C]{.ul}), 124.8 (16-[C]{.ul}), 124.6 (25-[C]{.ul}), 123.7 (26-[C]{.ul}), 122.4 (24-[C]{.ul}), 122.1 (27-[C]{.ul}), 122.0 (14-[C]{.ul}), 120.9 (17-[C]{.ul}), 119.6 (11-[C]{.ul}), 62.5 (28-[C]{.ul}), 62.2 (30-[C]{.ul}), 56.7 (8-[C]{.ul}), 54.7 (2-[C]{.ul}), 14.0 (29-[C]{.ul}), 13.8 (31-[C]{.ul}); MS (ESI): *m/z* = 455 \[M+H\]^+^, 477 \[M+Na\]^+^; MS (HREI): C~23~H~22~N~2~O~4~S~2~ Na for +, calculated 454.1021, found 454.1017; IR (KBr, cm^−1^) ν 3371, 2978, 1735, 1720, 1592, 1481, 1373, 1278, 1199, 829, 756.

*(+) Diethyl 2-(benzo\[b\]thiophen-2-yl(benzo\[d\]thiazol-2-ylamino)methyl)malonate* (**5bc**). This product was obtained as a white solid from a reaction catalyzed by **Q** (10 mol%) at 25 °C for 72 h; mp: 93--95 °C; yield: 52% after preparative column chromatography purification (silica gel: PE/ethyl ether = 7/1); 80.0% ee as determined by HPLC \[Daicel Chiralpak IA, hexane/EtOH = 75/25, 1.0 mL/min, λ = 254 nm, tr (major) = 8.65 min, tr (minor) = 10.57 min\]; ![](molecules-19-03955-i003.jpg) = +123.44 (c = 0.064 g/100 mL, CHCl~3~).

*Dipropyl 2-(benzo\[b\]thiophen-2-yl(benzo\[d\]thiazol-2-ylamino)methyl)malonate* (**5cr**). White solid; mp: 74--76 °C; yield: 68%; ^1^H-NMR (CDCl~3~) δ (ppm): 7.74 (d, 1H, *J* = 10 Hz, 24-C[H]{.ul}), 7.67 (d, 1H, *J* = 10 Hz, 27-C[H]{.ul}), 7.57 (t, 2H, *J* = 15 Hz, 14-C[H]{.ul}, 17-C[H]{.ul}), 7.31--7.26 (m, 4H, 25-C[H]{.ul}, 26-C[H]{.ul}, 15-C[H]{.ul}, 16-C[H]{.ul}), 7.09 (t, 1H, *J* = 15Hz, 11-C[H]{.ul}), 7.02 (s, 1H, N[H]{.ul}), 6.15 (d, 1H, *J* = 5 Hz, 8-C[H]{.ul}), 4.20 (d, 1H, *J* = 5 Hz, 2-C[H]{.ul}), 4.15--4.06 (m, 4H, 28-C[H~2~]{.ul}, 29-C[H~2~]{.ul}), 1.62--1.59 (m, 4H, 30-C[H~2~]{.ul}, 31-C[H~2~]{.ul}), 0.87--0.83 (m, 6H, 32-C[H~3~]{.ul}, 33-C[H~3~]{.ul}); ^13^C-NMR (CDCl~3~): δ (ppm) 168.3 (20-[C]{.ul}), 166.7 (1-[C]{.ul}), 165.7 (3-[C]{.ul}), 152.2 (10-[C]{.ul}), 143.4 (13-[C]{.ul}), 139.5 (22-[C]{.ul}), 131.0 (23-[C]{.ul}), 126.0 (12-[C]{.ul}), 124.6 (15-[C]{.ul}), 124.6 (16-[C]{.ul}), 124.5 (25-[C]{.ul}), 123.7 (26-[C]{.ul}), 122.3 (24-[C]{.ul}), 122.1 (27-[C]{.ul}), 122.0 (14-[C]{.ul}), 120.9 (17-[C]{.ul}), 119.7 (11-[C]{.ul}), 68.0 (28-[C]{.ul}), 67.8 (29-[C]{.ul}), 56.6 (8-[C]{.ul}), 54.7 (2-[C]{.ul}), 21.9 (30-[C]{.ul}), 21.8 (31-[C]{.ul}), 10.3 (32-[C]{.ul}), 10.2 (33-[C]{.ul}); MS (ESI): *m/z* = 483 \[M+H\]^+^, 505 \[M+Na\]^+^; MS (HREI): C~25~H~26~N~2~O~4~S~2~ Na for +, calculated 482.1334, found 482.1337; IR (KBr, cm^−1^) ν 3348, 2964, 1743, 1718, 1533, 1481, 1392, 1286, 1199, 837, 756.

*(+) Dipropyl 2-(benzo\[b\]thiophen-2-yl(benzo\[d\]thiazol-2-ylamino)methyl)malonate* (**5cc**). This product was obtained as a white solid from a reaction catalyzed by **Q** (10 mol%) at 25 °C for 96 h; mp: 74--76 °C; yield: 76% after column chromatography purification (silica gel, PE/ethyl ether = 7/1); 76.0% ee as determined by HPLC \[Daicel Chiralpak IA, hexane/EtOH = 75/25, 1.0 mL/min, λ = 254 nm, tr (major) = 7.45 min, tr (minor) = 9.54 min\]; ![](molecules-19-03955-i003.jpg) = +110.94 (c = 0.064 g/100 mL, CHCl~3~).

*Dibenzyl 2-(benzo\[b\]thiophen-2-yl(benzo\[d\]thiazol-2-ylamino)methyl)malonate* (**5dr**). White solid; mp: 117--119 °C; yield: 78%; ^1^H-NMR (CDCl~3~) δ (ppm): 7.72 (d, 1H, *J* = 5 Hz, 24-C[H]{.ul}), 7.62 (d, 1H, *J* = 5 Hz, 27-C[H]{.ul}), 7.57--7.53 (m, 2H, 14-C[H]{.ul}, 31-C[H]{.ul}), 7.31--7.27 (m, 3H, 32-C[H]{.ul}, 33-C[H]{.ul}, 34-C[H]{.ul}), 7.22--7.17 (m, 5H, 35-C[H]{.ul}, 37-C[H]{.ul}, 38-C[H]{.ul}, 39-C[H]{.ul}, 40-C[H]{.ul}), 7.15--7.10 (m, 7H, 41-C[H]{.ul}, 17-C[H]{.ul}, 25-C[H]{.ul}, 26-C[H]{.ul}, 15-C[H]{.ul}, 16-C[H]{.ul}, 11-C[H]{.ul}), 6.94 (s, 1H, N[H]{.ul}), 6.22 (d, 1H, *J* = 5 Hz, 8-C[H]{.ul}), 5.19-5.06 (m, 4H, 28-C[H~2~]{.ul}, 29-C[H~2~]{.ul}), 4.30 (d, 1H, *J* = 5 Hz, 2-C[H]{.ul}); ^13^C-NMR (CDCl~3~) δ (ppm): 168.0 (20-[C]{.ul}), 166.5 (1-[C]{.ul}), 166.3 (3-[C]{.ul}), 165.5 (10-[C]{.ul}), 152.1 (13-[C]{.ul}), 143.1 (22-[C]{.ul}), 139.5 (30-[C]{.ul}), 139.4 (36-[C]{.ul}), 134.7 (23-[C]{.ul}), 134.6 (32-[C]{.ul}), 131.1 (34-[C]{.ul}), 128.7 (38-[C]{.ul}), 128.6 (40-[C]{.ul}), 128.5 (12-[C]{.ul}), 128.5 (31-[C]{.ul}), 128.4 (35-[C]{.ul}), 128.3 (37-[C]{.ul}), 128.2 (41-[C]{.ul}), 128.1 (39-[C]{.ul}), 126.0 (33-[C]{.ul}), 124.6 (15-[C]{.ul}), 124.5 (26-[C]{.ul}), 123.8 (25-[C]{.ul}), 122.4 (16-[C]{.ul}), 122.2 (24-[C]{.ul}), 122.0 (17-[C]{.ul}), 120.9 (27-[C]{.ul}), 119.7 (14-[C]{.ul}), 68.2 (11-[C]{.ul}), 67.9 (28-[C]{.ul}), 56.7 (29-[C]{.ul}), 54.5 (8-[C]{.ul}), 42.3 (2-[C]{.ul}); MS (ESI): *m/z* = 483 \[M+H\]^+^, 505 \[M+Na\]^+^; MS (HREI): C~33~H~26~N~2~O~4~S~2~ Na for +, calculated 578.1334, found 578.1348; IR (KBr, cm^−1^) ν 3338, 2953, 1739, 1716, 1593, 1454, 1381, 1199, 827, 750.

*(+) Dibenzyl 2-(benzo\[b\]thiophen-2-yl(benzo\[d\]thiazol-2-ylamino)methyl)malonate* (**5dc**). This product was obtained as a white solid from a reaction catalyzed by **Q** (10 mol%) at 25 °C for 96 h; mp: 117--119 °C; yield: 76% after column chromatography purification (silica gel: PE/ethyl ether = 7/1); 92.0% ee as determined by HPLC \[Daicel Chiralpak IA, hexane/EtOH = 75/25, 1.0 mL/min, λ = 254 nm, tr (major) = 12.78 min, tr (minor) = 16.59 min\]; ![](molecules-19-03955-i003.jpg) = +106.17 (c = 0.081 g/100 mL, CHCl~3~).

*Dimethyl 2-(benzo\[b\]thiophen-2-yl((6-chlorobenzo\[d\]thiazol-2-yl)amino)methyl) malonate* (**5er**). White solid; mp: 145--147 °C; yield: 82%; ^1^H-NMR (CDCl~3~) δ (ppm):7.74 (d, 1H, *J* = 10 Hz, 24-C[H]{.ul}), 7.68 (d, 1H, *J* = 10Hz, 27-C[H]{.ul}), 7.52 (s, 1H, 14-C[H]{.ul}), 7.45 (d, 1H, *J* = 5 Hz, 17-C[H]{.ul}), 7.33--7.22 (m, 4H, 25-C[H]{.ul}, 26-C[H]{.ul}, 15-C[H]{.ul}, 11-C[H]{.ul}), 7.07 (s, 1H, N[H]{.ul}), 6.12 (s, 1H, 8-C[H]{.ul}), 4.20 (d, 1H, *J* = 5 Hz, 2-C[H]{.ul}), 3.73 (m, 6H, 29-C[H~3~]{.ul}, 30-C[H~3~]{.ul}); ^13^C-NMR (CDCl~3~): δ (ppm) 168.5 (20-[C]{.ul}), 166.9 (1-[C]{.ul}), 165.9 (3-[C]{.ul}), 150.8 (10-[C]{.ul}), 142.8 (13-[C]{.ul}), 139.5 (22-[C]{.ul}), 139.4 (23-[C]{.ul}), 132.2 (12-[C]{.ul}), 127.4 (15-[C]{.ul}), 126.5 (16-[C]{.ul}), 124.9 (25-[C]{.ul}), 124.7 (26-[C]{.ul}), 123.8 (24-[C]{.ul}), 122.4 (27-[C]{.ul}), 122.2 (14-[C]{.ul}), 120.6 (17-[C]{.ul}), 120.3 (11-[C]{.ul}), 56.3 (8-[C]{.ul}), 54.7 (2-[C]{.ul}), 53.4 (29-[C]{.ul}), 53.2 (30-[C]{.ul}); MS (ESI): *m/z* = 461 \[M+H\]^+^, 483 \[M+Na\]^+^; MS (HREI): C~21~H~17~ClN~2~O~4~S~2~ Na for +, calculated 460.0318, found 460.0307; IR (KBr, cm^−1^) ν 3354, 2951, 1745, 1741, 1595, 1435, 1359, 1195, 835, 756.

*(+) Dimethyl 2-(benzo\[b\]thiophen-2-yl((6-chlorobenzo\[d\]thiazol-2-yl)amino)methyl) malonate* (**5ec**). This product was obtained as a white solid from a reaction catalyzed by **Q** (10 mol%) at 25 °C for 72 h; mp: 145--147 °C, yield: 82% after column chromatography purification (silica gel: PE/ethyl ether = 7/1); 64.0% ee as determined by HPLC \[Daicel Chiralpak IA, hexane/EtOH = 75/25, 1.0 mL/min, λ = 254 nm, tr (major) = 13.95 min, tr (minor) = 20.91 min\]; ![](molecules-19-03955-i003.jpg) = +140.00 (c = 0.060 g/100 mL, CHCl~3~).

*Diethyl 2-(benzo\[b\]thiophen-2-yl((6-chlorobenzo\[d\]thiazol-2-yl)amino)methyl) malonate* (**5fr**). White solid; mp: 113--115 °C; yield: 78%; ^1^H-NMR (CDCl~3~) δ (ppm): 7.74 (d, 1H, *J* = 10 Hz, 24-C[H]{.ul}), 7.68 (d, 1H, *J* = 10 Hz, 27-C[H]{.ul}), 7.53--7.5 2(m, 1H, 14-C[H]{.ul}), 7.45--7.42 (m, 1H, 17-C[H]{.ul}), 7.33--7.22 (m, 4H, 26-C[H]{.ul}, 15-C[H]{.ul}, 16-C[H]{.ul}, 11-C[H]{.ul}), 7.07 (s, 1H, N[H]{.ul}), 6.14 (s, 1H, 8-C[H]{.ul}), 4.25 (d, 1H, *J* = 5 Hz, 2-C[H]{.ul}), 4.22--4.14 (m, 4H, 28-C[H~2~]{.ul}, 30-C[H~2~]{.ul}), 1.22--1.16 (m, 6H, 29-C[H~3~]{.ul}, 31-C[H~3~]{.ul}); ^13^C-NMR (CDCl~3~) δ (ppm): 168.2 (20-[C]{.ul}), 166.5 (1-[C]{.ul}), 165.8 (3-[C]{.ul}), 150.8 (10-[C]{.ul}), 143.1(13-[C]{.ul}), 139.4 (22-[C]{.ul}), 132.2 (23-[C]{.ul}), 127.3 (12-[C]{.ul}), 126.5 (15-[C]{.ul}), 124.8 (16-[C]{.ul}), 124.7 (25-[C]{.ul}), 124.6 (26-[C]{.ul}), 123.8 (24-[C]{.ul}), 122.4 (27-[C]{.ul}), 122.0 (14-[C]{.ul}), 120.6 (17-[C]{.ul}), 120.3 (11-[C]{.ul}), 62.6 (28-[C]{.ul}), 62.3 (30-[C]{.ul}), 56.5 (8-[C]{.ul}), 54.7 (2-[C]{.ul}), 14.0 (29-[C]{.ul}), 13.9 (31-[C]{.ul}); MS (ESI): *m/z* = 489 \[M+H\]^+^, 511 \[M+Na\]^+^; MS (HREI): C~23~H~21~ClN~2~O~4~S~2~ Na for +, calculated 488.0631, found 488.0625; IR (KBr, cm^−1^) ν 3354, 2978, 1743, 1720, 1593, 1444, 1093, 873, 761.

*(+) Diethyl 2-(benzo\[b\]thiophen-2-yl((6-chlorobenzo\[d\]thiazol-2-yl)amino)methyl) malonate* (**5fc**). This product was obtained as a white solid from a reaction catalyzed by **Q** (10 mol%) at 25 °C for 72 h; mp: 113--115 °C; yield: 76% after column chromatography purification (silica gel, PE/ethyl ether = 7/1); 82.0% ee as determined by HPLC \[Daicel Chiralpak IA, hexane/EtOH = 75/25, 1.0 mL/min, λ = 254 nm, tr (major) = 11.14 min, tr (minor) = 19.58 min\]; ![](molecules-19-03955-i003.jpg) = +147.54 (c = 0.061 g/100 mL, CHCl~3~).

*Dipropyl 2-(benzo\[b\]thiophen-2-yl((6-chlorobenzo\[d\]thiazol-2-yl)amino)methyl) malonate* (**5gr**). White solid; mp: 92--94 °C; yield: 76%, ^1^H-NMR (CDCl~3~) δ (ppm): 7.75 (d, 1H, *J* = 5 Hz, 24-CH), 7.68 (d, 1H, *J* = 5 Hz, 27-C[H]{.ul}), 7.44 (d, 1H, *J* = 10 Hz, 14-C[H]{.ul}), 7.33--7.21 (m, 5H, 17-C[H]{.ul}, 25-C[H]{.ul}, 26-C[H]{.ul}, 15-C[H]{.ul}, 11-C[H]{.ul}), 7.08 (s, 1H, N[H]{.ul}), 6.14 (s, 1H, 8-C[H]{.ul}), 4.18 (d, 1H, *J* = 5 Hz, 2-C[H]{.ul}), 4.15--4.04 (m, 4H, 29-C[H~2~]{.ul}, 30-C[H~2~]{.ul}), 1.63--1.55 (m, 4H, 31-C[H~2~]{.ul}, 32-C[H~2~]{.ul}), 0.87--0.83 (m, 6H, 33-C[H~3~]{.ul}, 34-CH~3~); ^13^C-NMR (CDCl~3~) δ (ppm): 168.3 (20-[C]{.ul}), 166.6 (1-[C]{.ul}), 165.8 (3-[C]{.ul}), 150.8 (10-[C]{.ul}), 143.1 (13-[C]{.ul}), 139.5 (22-[C]{.ul}), 139.4 (23-[C]{.ul}), 132.2 (12-[C]{.ul}), 127.3 (15-[C]{.ul}), 126.4 (16-[C]{.ul}), 124.6 (25-[C]{.ul}), 124.5 (26-[C]{.ul}), 123.7 (24-[C]{.ul}), 122.4 (27-[C]{.ul}), 122.0 (14-[C]{.ul}), 120.5 (17-[C]{.ul}), 120.3 (11-[C]{.ul}), 68.1 (29-[C]{.ul}), 67.8 (30-[C]{.ul}), 56.5 (8-[C]{.ul}), 54.6 (2-[C]{.ul}), 21.9 (31-[C]{.ul}), 21.8 (32-[C]{.ul}), 10.3 (33-[C]{.ul}), 10.2 (34-[C]{.ul}); MS (ESI): *m/z* = 517 \[M+H\]^+^, 539 \[M+Na\]^+^; MS (HREI): C~25~H~25~ClN~2~O~4~S~2~ Na for +, calculated 516.0944, found 516.0932; IR (KBr, cm^−1^) ν 3354, 2964, 1747, 1722, 1593, 1479, 1199, 1170, 875, 754.

*(+) Dipropyl 2-(benzo\[b\]thiophen-2-yl((6-chlorobenzo\[d\]thiazol-2-yl)amino)methyl) malonate* (**5gc**). This product was obtained as a white solid from a reaction catalyzed by **Q** (10 mol%) at 25 °C for 96 h; mp: 92--94 °C, yield: 75% after column chromatography purification (silica gel, PE/ethyl ether = 7/1); 80.0% ee as determined by HPLC \[Daicel Chiralpak IA, hexane/EtOH = 75/25, 1.0 mL/min, λ = 254 nm, tr (major) = 8.89 min, tr (minor) = 17.20 min\]; ![](molecules-19-03955-i003.jpg) = +124.62 (c = 0.065 g/100 mL, CHCl~3~).

*Dibenzyl 2-(benzo\[b\]thiophen-2-yl((6-chlorobenzo\[d\]thiazol-2-yl)amino)methyl) malonate* (**5hr**). White solid; mp: 125--127 °C; yield: 82%, ^1^H-NMR (CDCl~3~) δ (ppm):7.72 (d, 1H, *J* = 5 Hz, 24-C[H]{.ul}), 7.62 (d, 1H, *J* = 5 Hz, 27-C[H]{.ul}), 7.51 (s, 1H, 14-C[H]{.ul}), 7.41 (d, 1H, *J* = 10 Hz, 31-C[H]{.ul}), 7.32--7.27 (m, 2H, 32-C[H]{.ul}, 33-C[H]{.ul}), 7.25--7.09 (m, 12H, 34-C[H]{.ul}, 35-C[H]{.ul}, 37-C[H]{.ul}, 38-C[H]{.ul}, 39-C[H]{.ul}, 40-C[H]{.ul}, 17-C[H]{.ul}, 41-C[H]{.ul}, 15-C[H]{.ul}, 25-C[H]{.ul}, 11-C[H]{.ul}, 26-C[H]{.ul}), 7.08 (s, 1H, N[H]{.ul}), 6.19 (s, 1H, 8-C[H]{.ul}), 5.20-5.04 (m, 4H, 28-C[H]{.ul}~2~, 29-C[H]{.ul}~2~), 4.28 ( d, 1H, *J* = 10 Hz, 2-CH); ^13^C-NMR (CDCl~3~) δ (ppm): 168.0 (20-[C]{.ul}), 166.2 (1-[C]{.ul}), 165.6 (3-[C]{.ul}), 150.8 (10-[C]{.ul}), 142.8 (13-[C]{.ul}), 139.5 (22-[C]{.ul}), 139.4 (30-[C]{.ul}), 134.7 (36-[C]{.ul}), 134.6 (23-[C]{.ul}), 132.3 (32-[C]{.ul}), 128.7 (34-[C]{.ul}), 128.6 (38-[C]{.ul}), 128.6 (40-[C]{.ul}), 128.5 (12-[C]{.ul}), 128.5 (31-[C]{.ul}), 128.5 (35-[C]{.ul}), 128.4 (37-[C]{.ul}), 128.4 (41-[C]{.ul}), 128.2 (39-[C]{.ul}), 128.0 (33-[C]{.ul}), 127.4 (15-[C]{.ul}), 126.5 (26-[C]{.ul}), 124.6 (25-[C]{.ul}), 123.2 (16-[C]{.ul}), 121.4 (24-[C]{.ul}), 120.5 (17-[C]{.ul}), 120.4 (27-[C]{.ul}), 111.3 (14-[C]{.ul}), 104.7 (11-[C]{.ul}), 68.3 (28-[C]{.ul}), 68.0 (29-[C]{.ul}), 56.6 (8-[C]{.ul}), 54.5 (2-[C]{.ul}); MS (ESI): *m/z* = 613 \[M+H\]^+^, 635 \[M+Na\]^+^; MS (HREI): C~33~H~25~ClN~2~O~4~S~2~ Na for +, calculated 612.0944, found 612.0950; IR (KBr, cm^−1^) ν 3344, 2956, 1741, 1720, 1591, 1483, 1382, 1259, 1188, 827, 740.

*(+) Dibenzyl 2-(benzo\[b\]thiophen-2-yl((6-chlorobenzo\[d\]thiazol-2-yl)amino)methyl) malonate* (**5hc**). This product was obtained as a white solid from a reaction catalyzed by **Q** (10 mol%) at 25 °C for 96 h; mp: 125--127 °C; yield: 82% after column chromatography purification (Column chromatographic silica gel, PE/ethyl ether = 7/1); \>99.0% ee as determined by HPLC \[Daicel Chiralpak IA, hexane/EtOH =75/25, 1.0 mL/min, λ = 254 nm, tr (major) = 14.322 min, tr (minor) = 28.00 min\]; ![](molecules-19-03955-i003.jpg) = +160.81 (c = 0.074 g/100 mL, CHCl~3~).

*Dimethyl 2-(benzo\[b\]thiophen-2-yl((6-methoxybenzo\[d\]thiazol-2-yl)amino) methyl)malonate* (**5ir**). White solid; mp: 78--80 °C; yield: 83%; ^1^H-NMR (CDCl~3~) δ (ppm):7.74--7.73 (d, 1H, *J* = 5 Hz, 24-C[H]{.ul}), 7.68 (d, 1H, *J* = 5 Hz, 27-C[H]{.ul}), 7.46 (d, 1H, *J* = 5 Hz, 14-C[H]{.ul}), 7.32--7.25 (m, 3H, 17-C[H]{.ul}, 25-C[H]{.ul}, 26-C[H]{.ul}), 7.10 (s, 1H, 15-C[H]{.ul}), 6.88 (d, 1H, *J* = 5 Hz, 11-C[H]{.ul}), 6.10 (s, 1H, N[H]{.ul}), 5.29 (s, 1H, 8-C[H]{.ul}), 4.20 (d, 1H, *J* = 5 Hz, 2-C[H]{.ul}), 3.79 (s, 3H, 29-OCH~3~), 3.73 (s, 6H, 31-C[H~3~]{.ul}, 31-C[H~3~]{.ul}); ^13^C-NMR (CDCl~3~) δ (ppm): 168.4 (20-[C]{.ul}), 167.0 (1-[C]{.ul}), 164.0 (3-[C]{.ul}), 155.6 (10-[C]{.ul}), 146.3 (13-[C]{.ul}), 143.3 (22-[C]{.ul}), 139.5 (23-[C]{.ul}), 139.4 (12-[C]{.ul}), 132.0 (15-[C]{.ul}), 124.6 (16-[C]{.ul}), 124.5 (25-[C]{.ul}), 123.8 (26-[C]{.ul}), 122.4 (24-[C]{.ul}), 122.0 (27-[C]{.ul}), 120.0 (14-[C]{.ul}), 113.7 (17-[C]{.ul}), 105.3 (11-[C]{.ul}), 56.4 (8-[C]{.ul}), 56.0 (2-[C]{.ul}), 54.7 (29-[C]{.ul}), 53.0 (30-[C]{.ul}), 53.1 (31-[C]{.ul}); MS (ESI): *m/z* = 457 (\[M+H\]^+^), 479 (\[M+Na\]^+^); MS (HREI): C~22~H~20~N~2~O~5~S~2~ Na for +, calculated 456.0814, found 456.0847; IR (KBr, cm^−1^) ν 3346, 2951, 1743, 1722, 1541, 1473, 1355, 1277, 1058, 819, 742.

*(+) Dimethyl 2-(benzo\[b\]thiophen-2-yl((6-methoxybenzo\[d\]thiazol-2-yl)amino) methyl)malonate* (**5ic**). This product was obtained as a white solid from a reaction catalyzed by **Q** (10 mol%) at 25 °C for 72 h; mp: 78--80 °C; yield: 81% after column chromatography purification (silica gel, PE/ethyl ether = 7/1); 80.0% ee as determined by HPLC \[Daicel Chiralpak IA, hexane/EtOH =75/25, 1.0 mL/min, λ = 254 nm, tr (major) = 15.67 min, tr (minor) = 18.49 min\]; ![](molecules-19-03955-i003.jpg) = +136.73 (c = 0.049 g/100 mL, CHCl~3~).

*Diethyl 2-(benzo\[b\]thiophen-2-yl((6-methoxybenzo\[d\]thiazol-2-yl)amino)methyl) malonate* (**5jr**). White solid; mp: 74--76 °C; yield: 81%; ^1^H-NMR (CDCl~3~) δ (ppm): 7.46 (t, 2H, *J* = 20 Hz, 24-C[H]{.ul}, 27-C[H]{.ul}), 7.41 (d, 1H, *J* = 5 Hz, 14-C[H]{.ul}), 7.24 (t, 1H, *J* = 15 Hz, 17-C[H]{.ul}), 7.18 (t, 1H, *J* = 15 Hz, 26-C[H]{.ul}), 7.12 (d, 1H, *J* = 5 Hz, 15-C[H]{.ul}), 6.72 (s, 1H, 11-C[H]{.ul}), 6.67 (s, 1H, N[H]{.ul}), 6.01 (s, 1H, 8-C[H]{.ul}), 4.28 (d, 1H, *J* = 5 Hz, 2-C[H]{.ul}), 4.24--4.14 (m, 4H, 28-C[H~2~]{.ul}, 30-C[H~2~]{.ul}), 3.80 (s, 3H, 25-OC[H~3~]{.ul}), 1.20--1.17 (m, 6H, 29-C[H~3~]{.ul}, 31-C[H~3~]{.ul}); ^13^C-NMR (CDCl~3~) δ (ppm): 168.1 (20-[C]{.ul}), 166.7 (1-[C]{.ul}), 164.1 (3-[C]{.ul}), 155.6 (10-[C]{.ul}), 146.3 (13-[C]{.ul}), 143.5 (22-[C]{.ul}), 139.5 (23-[C]{.ul}), 131.9 (12-[C]{.ul}), 124.7 (15-[C]{.ul}), 124.6 (16-[C]{.ul}), 124.5 (25-[C]{.ul}), 123.7 (26-[C]{.ul}), 122.3 (24-[C]{.ul}), 122.0 (27-[C]{.ul}), 120.0 (14-[C]{.ul}), 113.7 (17-[C]{.ul}), 105.3 (11-[C]{.ul}), 62.5 (28-[C]{.ul}), 62.2 (30-[C]{.ul}), 56.7 (8-[C]{.ul}), 56.0 (2-[C]{.ul}), 54.7 (25-[C]{.ul}), 14.1 (29-[C]{.ul}), 14.0 (31-[C]{.ul}); MS (ESI): *m/z* = 485 \[M+H\]^+^, 507 \[M+Na\]^+^; MS HREI): C~24~H~24~N~2~O~5~S~2~ Na for +, calculated 484.1127, found 484.1118; IR (KBr, cm^−1^) ν 3321, 2956, 1747, 1718, 1543, 1458, 1276, 1193, 840, 750.

*(+) Diethyl 2-(benzo\[b\]thiophen-2-yl((6-methoxybenzo\[d\]thiazol-2-yl)amino)methyl) malonate* (**5jc**). This product was obtained as a white solid from a reaction catalyzed by **Q** (10 mol%) at 25 °C for 72 h; mp: 78--80 °C; yield: 81% after column chromatography purification (silica gel: PE/ethyl ether = 7/1); 80.0% ee as determined by HPLC \[Daicel Chiralpak IA, hexane/EtOH = 75/25, 1.0 mL/min, λ = 254 nm, tr (major) = 11.75 min, tr (minor) = 16.49 min\]; ![](molecules-19-03955-i003.jpg) = +160.46 (c = 0.043 g/100 mL, CHCl~3~).

*Dipropyl 2-(benzo\[b\]thiophen-2-yl((6-methoxybenzo\[d\]thiazol-2-yl)amino)methyl) malonate* (**5kr**). White solid; mp: 99--101 °C; yield: 78%; ^1^H-NMR (CDCl~3~) δ (ppm): 7.74 (d, 1H, *J* = 10 Hz, 24-C[H]{.ul}), 7.67 (d, 1H, *J* = 10 Hz, 27-C[H]{.ul}), 7.45 (d, 1H, *J* = 10 Hz, 14-C[H]{.ul}), 7.32--7.26 (m, 4H, 17-C[H]{.ul}, 25-C[H]{.ul}, 26-C[H]{.ul}, 15-C[H]{.ul}), 7.11 (d, 1H, *J* = 5 Hz, 11-C[H]{.ul}), 6.89 (s, 1H, N[H]{.ul}), 6.11 (d, 1H, *J* = 5 Hz, 8-C[H]{.ul}), 4.18 (d, 1H, *J* = 5 Hz, 2-C[H]{.ul}), 4.14--4.05 (m, 4H, 29-C[H]{.ul}~2~, 30-C[H~2~]{.ul}), 3.80 (s, 3H, 28-OC[H~3~]{.ul}), 1.63--1.55 (m, 4H, 31-C[H~2~]{.ul}, 32-C[H~2~]{.ul}), 0.87--0.83 (m, 6H, 33-C[H~3~]{.ul}, 34-C[H~3~]{.ul}); ^13^C-NMR (CDCl~3~): δ (ppm) 168.3 (20-[C]{.ul}), 166.7 (1-[C]{.ul}), 164.0 (3-[C]{.ul}), 155.5 (10-[C]{.ul}), 146.3 (13-[C]{.ul}), 143.6 (22-[C]{.ul}), 139.5 (23-[C]{.ul}), 132.0 (12-[C]{.ul}), 124.9 (15-[C]{.ul}), 124.8 (16-[C]{.ul}), 124.5 (25-[C]{.ul}), 123.7 (26-[C]{.ul}), 122.3 (24-[C]{.ul}), 122.0 (27-[C]{.ul}), 120.0 (14-[C]{.ul}), 113.6 (17-[C]{.ul}), 105.3 (11-[C]{.ul}), 68.0 (29-[C]{.ul}), 67.7 (30-[C]{.ul}), 56.7 (8-[C]{.ul}), 56.0 (2-[C]{.ul}), 54.6 (28-[C]{.ul}), 21.9 (31-[C]{.ul}), 21.8 (32-[C]{.ul}), 10.3 (33-[C]{.ul}), 10.2 (34-[C]{.ul}); MS (ESI): *m/z* = 513 \[M+H\]^+^, 535 \[M+Na\]^+^; MS (HREI): C~26~H~28~N~2~O~5~S~2~ Na for +, calculated 512.1440, found 512.1429; IR (KBr, cm^−1^) ν 3331, 2962, 1747, 1718, 1543, 1276, 1190, 825, 752.

*(+) Dipropyl 2-(benzo\[b\]thiophen-2-yl((6-methoxybenzo\[d\]thiazol-2-yl)amino) methyl)malonate* (**5kc**). This product was obtained as a white solid from a reaction catalyzed by **Q** (10 mol%) at 25 °C for 96 h; mp: 99--101 °C; yield: 77% after column chromatography purification (silica gel, PE/ethyl ether = 7/1); 70.0% ee as determined by HPLC \[Daicel Chiralpak IA, hexane/EtOH = 75/25, 1.0 mL/min, λ = 254 nm, tr (major) = 9.80 min, tr (minor) = 14.84 min\]; ![](molecules-19-03955-i003.jpg) = +138.18 (c = 0.055 g/100 mL, CHCl~3~).

*Dibenzyl 2-(benzo\[b\]thiophen-2-yl((6-methoxybenzo\[d\]thiazol-2-yl)amino)methyl) malonate* (**5lr**). White solid; mp: 108--110 °C; yield: 78%; ^1^H-NMR (CDCl~3~) δ (ppm): 7.72 (d, 1H, *J* = 5 Hz, 24-C[H]{.ul}), 7.62 (d, 1H, *J* = 5 Hz, 27-C[H]{.ul}), 7.44 (d, 1H, *J* = 5 Hz, 14-C[H]{.ul}), 7.31--7.28 (m, 3H, 31-C[H]{.ul}, 32-C[H]{.ul}, 33-C[H]{.ul}), 7.25 (s, 1H, N[H]{.ul}), 7.22--7.20 (m, 3H, 34-C[H]{.ul}, 35-C[H]{.ul}, 37-C[H]{.ul}), 7.17--7.10 (m, 8H, 38-C[H]{.ul}, 39-C[H]{.ul}, 40-C[H]{.ul}, 17-C[H]{.ul}, 41-C[H]{.ul}, 15-C[H]{.ul}, 26-C[H]{.ul}, 11-C[H]{.ul}), 6.89 (d, 1H, *J* = 10 Hz, 26-C[H]{.ul}), 6.18 (s, 1H, 8-C[H]{.ul}), 5.16--5.06 (m, 4H, 28-CH~2~, 29-CH~2~), 4.29 (d, 1H, *J* = 5 Hz, 2-C[H]{.ul}), 3.81 (s, 3H, 25-OC[H~3~]{.ul}); ^13^C-NMR (CDCl~3~): δ (ppm) 167.9 (20-[C]{.ul}), 166.3 (1-[C]{.ul}), 163.8 (3-[C]{.ul}), 155.6 (10-[C]{.ul}), 146.4 (13-[C]{.ul}), 143.2 (22-[C]{.ul}), 139.5 (30-[C]{.ul}), 134.8 (36-[C]{.ul}), 134.7 (23-[C]{.ul}), 132.1 (32-[C]{.ul}), 128.7 (34-[C]{.ul}), 128.6 (38-[C]{.ul}), 128.5 (40-[C]{.ul}), 128.5 (12-[C]{.ul}), 128.5 (31-[C]{.ul}), 128.4 (35-[C]{.ul}), 128.4 (37-[C]{.ul}), 128.3 (41-[C]{.ul}), 128.2 (39-[C]{.ul}), 128.1 (33-[C]{.ul}), 124.4 (15-[C]{.ul}), 123.1 (26-[C]{.ul}), 121.3 (25-[C]{.ul}), 120.1 (16-[C]{.ul}), 113.7 (24-[C]{.ul}), 111.3 (17-[C]{.ul}), 105.3 (27-[C]{.ul}), 104.7 (14-[C]{.ul}), 68.2 (11-[C]{.ul}), 67.9 (28-[C]{.ul}), 67.8 (29-[C]{.ul}), 56.7 (25-[C]{.ul}), 56.0 (8-[C]{.ul}), 54.5 (2-[C]{.ul}); MS(ESI): *m/z* = 609 \[M+H\]^+^, 631 \[M+Na\]^+^; MS (HREI): C~34~H~28~N~2~O~5~S~2~ Na for +, calculated 608.1440, found 608.1440; IR (KBr, cm^−1^) ν 3361, 2358, 1747, 1716, 1541, 1471, 1222, 1101, 817, 740.

*(+)Dibenzyl 2-(benzo\[b\]thiophen-2-yl((6-methoxybenzo\[d\]thiazol-2-yl)amino) methyl)malonate* (**5lc**). This product was obtained as a white solid from a reaction catalyzed by **Q** (10 mol%) at 25 °C for 96 h; mp: 108--110 °C; yield: 78% after column chromatography purification (silica gel, PE/ethyl ether = 7/1); 89.0% ee as determined by HPLC \[Daicel Chiralpak IA, hexane/EtOH =75/25, 1.0 mL/min, λ = 254 nm, tr (major) = 15.58 min, tr (minor) = 23.21 min\]; ![](molecules-19-03955-i003.jpg) = +125 (c = 0.036 g/100 mL, CHCl~3~).

*Dimethyl 2-(benzo\[b\]thiophen-2-yl((6-methylbenzo\[d\]thiazol-2-yl)amino)methyl) malonate* (**5mr**). White solid; mp: 110--112 °C; yield: 82%; ^1^H-NMR (CDCl~3~) δ (ppm): 7.75 (d, 1H, *J* = 5 Hz, 24-C[H]{.ul}), 7.69 (d, 1H, *J* = 5 Hz, 27-C[H]{.ul}), 7.45 (d, 1H, *J* = 5 Hz, 14-C[H]{.ul}), 7.38 (s, 1H, 17-C[H]{.ul}), 7.33--7.27 (m, 3H, 25-C[H]{.ul}, 26-C[H]{.ul}, 15-C[H]{.ul}), 7.09 (d, 1H, *J* = 10 Hz, 11-C[H]{.ul}), 6.85 (s, 1H, N[H]{.ul}), 6.12 (s, 1H, 8-C[H]{.ul}), 4.21 (d, 1H, *J* = 5 Hz, 2-C[H]{.ul}), 3.73 (s, 6H, 29-C[H~3~]{.ul}, 30-C[H~3~]{.ul}), 2.38 (s, 3H, 28-C[H~3~]{.ul}); ^13^C-NMR (CDCl~3~) δ (ppm): 168.4 (20-[C]{.ul}), 167.0 (1-[C]{.ul}), 165.0 (3-[C]{.ul}), 150.0 (10-[C]{.ul}), 143.7 (13-[C]{.ul}), 139.5 (22-[C]{.ul}), 132.0 (23-[C]{.ul}), 131.0 (12-[C]{.ul}), 127.2 (15-[C]{.ul}), 124.8 (16-[C]{.ul}), 124.6 (25-[C]{.ul}), 124.5 (26-[C]{.ul}), 123.8 (24-[C]{.ul}), 122.4 (27-[C]{.ul}), 122.0 (14-[C]{.ul}), 121.1 (17-[C]{.ul}), 119.3 (11-[C]{.ul}), 56.4 (8-[C]{.ul}), 54.7 (2-[C]{.ul}), 53.3 (29-[C]{.ul}), 53.1 (30-[C]{.ul}), 21.3 (28-[C]{.ul}); MS (ESI): *m/z* = 441 \[M+H\]^+^, 463 \[M+Na\]^+^; MS (HREI): C~22~H~20~N~2~O~4~S~2~ Na for +, calculated 440.0864, found 440.0852; IR (KBr, cm^−1^) ν 3361, 2951, 1743, 1732, 1541, 1479, 1359, 1233, 1161, 815, 748.

*(+) Dimethyl 2-(benzo\[b\]thiophen-2-yl((6-methylbenzo\[d\]thiazol-2-yl)amino)methyl) malonate* (**5mc**). This product was obtained as a white solid from a reaction catalyzed by **Q** (10 mol%) at 25 °C for 72 h; mp: 110--112 °C; yield: 82% after column chromatography purification (silica gel: PE/ethyl ether = 7/1); 78.0% ee as determined by HPLC \[Daicel Chiralpak AD-H, hexane/EtOH = 75/25, 1.0 mL/min, λ = 254 nm, tr (major) = 26.94 min, tr (minor) = 24.52 min\]; ![](molecules-19-03955-i003.jpg) = +125.93 (c = 0.054 g/100 mL, CHCl~3~).

*Diethyl 2-(benzo\[b\]thiophen-2-yl((6-methylbenzo\[d\]thiazol-2-yl)amino)methyl) malonate* (**5nr**). White solid; mp: 115--117 °C; yield: 80%; ^1^H-NMR (CDCl~3~) δ (ppm): 7.78--7.74 (m, 1H, 24-C[H]{.ul}), 7.76--7.67 (m, 1H, 27-C[H]{.ul}), 7.47--7.43 (m, 1H, 14-C[H]{.ul}), 7.40--7.38 (m, 1H, 17-C[H]{.ul}), 7.32--7.26 (m, 3H, 26-C[H]{.ul}, 15-C[H]{.ul}, 16-C[H]{.ul}), 7.12--7.08 (m, 1H, 11-C[H]{.ul}), 6.92 (s, 1H, N[H]{.ul}), 6.14 (s, 1H, 8-C[H]{.ul}), 4.26--4.22 (m, 1H, 2-C[H]{.ul}), 4.20--4.16 (m, 4H, 28-C[H~2~]{.ul}, 30-C[H~2~]{.ul}), 2.41--2.38 (m, 3H, 25-C[H]{.ul}~3~), 1.24--1.17 (m, 6H, 29-C[H~3~]{.ul}, 31-C[H~3~]{.ul}); ^13^C-NMR (CDCl~3~) δ (ppm): 168.1 (20-[C]{.ul}), 166.7 (1-[C]{.ul}), 165.1 (3-[C]{.ul}), 150.2 (10-[C]{.ul}), 150.0 (13-[C]{.ul}), 143.5 (22-[C]{.ul}), 139.5 (23-[C]{.ul}), 132.1 (12-[C]{.ul}), 131.0 (15-[C]{.ul}), 127.2 (16-[C]{.ul}), 124.5 (25-[C]{.ul}), 123.7 (26-[C]{.ul}), 122.3 (24-[C]{.ul}), 121.9 (27-[C]{.ul}), 121.2 (14-[C]{.ul}), 121.0 (17-[C]{.ul}), 119.2 (11-[C]{.ul}), 62.5 (28-[C]{.ul}), 62.2 (30-[C]{.ul}), 56.6 (8-[C]{.ul}), 54.7 (2-[C]{.ul}), 21.3 (25-[C]{.ul}), 14.3 (29-[C]{.ul}), 14.0 (31-[C]{.ul}); MS (ESI): *m/z* = 469 \[M+H\]^+^, 491 \[M+Na\]^+^; MS (HREI): C~24~H~24~N~2~O~4~S~2~ Na for +, calculated 468.1177, found 468.1179; IR (KBr, cm^−1^) ν 3363, 2974, 1741, 1714, 1541, 1485, 1238, 1157, 1095, 817, 763.

*(+) Diethyl 2-(benzo\[b\]thiophen-2-yl((6-methylbenzo\[d\]thiazol-2-yl)amino)methyl) malonate* (**5nc**). this product was obtained as a white solid from a reaction catalyzed by **Q** (10 mol%) at 25 °C for 72 h; mp: 115--117 °C; yield: 80% after column chromatography purification (silica gel, PE/ethyl ether = 7/1); 76.0% ee as determined by HPLC \[Daicel Chiralpak IA, Hexane/EtOH = 75/25, 1.0 mL/min, λ = 254 nm, tr (major) = 9.90 min, tr (minor) = 11.94 min\]; ![](molecules-19-03955-i003.jpg) = +204.17 (c = 0.024 g/100 mL, CHCl~3~).

*Dipropyl 2-(benzo\[b\]thiophen-2-yl((6-methylbenzo\[d\]thiazol-2-yl)amino)methyl) malonate* (**5or**). White solid; mp: 109--111 °C; yield: 76%; ^1^H-NMR (CDCl~3~) δ (ppm):7.73 (d, 1H, *J* = 10 Hz, 24-C[H]{.ul}), 7.66 (d, 1H, *J* = 10 Hz, 27-C[H]{.ul}), 7.42 (t, 1H, *J* = 15 Hz, 14-C[H]{.ul}), 7.37 (s, 1H, 17-C[H]{.ul}), 7.27--7.25 (m, 3H, 25-C[H]{.ul}, 26-C[H]{.ul}, 15-C[H]{.ul}), 7.09--7.06 (m, 1H, 11-C[H]{.ul}), 6.91 (s, 1H, N[H]{.ul}), 6.11 (s, 1H, 8-C[H]{.ul}), 4.17 (d, 1H, *J* = 10 Hz, 2-C[H]{.ul}), 4.12--4.06 (m, 4H, 29-C[H~2~]{.ul}, 30-C[H~2~]{.ul}), 2.37 (s, 3H, 28-C[H~3~]{.ul}), 1.60--1.57 (m, 4H, 31-C[H~2~]{.ul}, 32-C[H~2~]{.ul}), 0.85--0.82 (m, 6H, 33-C[H~3~]{.ul}, 34-C[H~3~]{.ul}); ^13^C-NMR (CDCl~3~) δ (ppm): 168.3 (20-[C]{.ul}), 166.7 (1-[C]{.ul}), 165.0 (3-[C]{.ul}), 150.0 (10-[C]{.ul}), 143.5 (13-[C]{.ul}), 139.5 (22-[C]{.ul}), 131.9 (23-[C]{.ul}), 131.0 (12-[C]{.ul}), 127.1 (15-[C]{.ul}), 124.7 (16-C), 124.6 (25-[C]{.ul}), 124.5 (26-[C]{.ul}), 123.7 (24-[C]{.ul}), 122.3 (27-[C]{.ul}), 121.9 (14-[C]{.ul}), 120.9 (17-[C]{.ul}), 119.2 (11-[C]{.ul}), 68.0 (29-[C]{.ul}), 67.7 (30-[C]{.ul}), 56.6 (8-[C]{.ul}), 54.7 (2-[C]{.ul}), 21.9 (28-[C]{.ul}), 21.8 (31-[C]{.ul}), 21.3 (32-[C]{.ul}), 10.2 (33-[C]{.ul}), 10.0 (34-[C]{.ul}); MS (ESI): *m/z* = 497 \[M+H\]^+^, 519 \[M+Na\]^+^; MS (HREI): C~26~H~28~N~2~O~4~S~2~ Na for +, calculated 496.1490, found 496.1491; IR (KBr, cm^−1^) ν 3332, 2962, 1740, 1724, 1541, 1238, 1157, 812, 763.

*(+) Dipropyl 2-(benzo\[b\]thiophen-2-yl((6-methylbenzo\[d\]thiazol-2-yl)amino)methyl) malonate* (**5oc**). This product was obtained as a white solid from a reaction catalyzed by **Q** (10 mol%) at 25 °C for 96 h; mp: 109--111 °C; yield: 75% after column chromatography purification (silica gel, PE/ethyl ether = 7/1); 80.0% ee as determined by HPLC \[Daicel Chiralpak IA, Hexane/EtOH = 75/25, 1.0 mL/min, λ = 254 nm, tr (major) = 8.32 min, tr (minor) = 10.77 min\]; ![](molecules-19-03955-i003.jpg) = +78.12 (c = 0.064 g/100 mL, CHCl~3~).

*Dibenzyl 2-(benzo\[b\]thiophen-2-yl((6-methylbenzo\[d\]thiazol-2-yl)amino)methyl) malonate* (**5pr**). White solid; mp: 126--128 °C; yield: 80%; ^1^H-NMR (CDCl~3~) δ (ppm): 7.71 (d, 1H, *J* = 5 Hz, 24-C[H]{.ul}), 7.61 (d, 1H, *J* = 5 Hz, 27-C[H]{.ul}), 7.43 (d, 1H, *J* = 5 Hz, 14-C[H]{.ul}), 7.35 (s, 1H, N[H]{.ul}), 7.30--7.27 (m, 2H, 31-C[H]{.ul}, 32-C[H]{.ul}), 7.19--7.08 (m, 13H, 33-C[H]{.ul}, 34-C[H]{.ul}, 35-C[H]{.ul}, 37-C[H]{.ul}, 38-C[H]{.ul}, 39-C[H]{.ul}, 40-C[H]{.ul}, 17-C[H]{.ul}, 41-C[H]{.ul}, 15-C[H]{.ul}, 16-C[H]{.ul}, 11-C[H]{.ul}, 26-C[H]{.ul}), 6.19 (s, 1H, 8-C[H]{.ul}), 5.16--5.05 (m, 4H, 28-C[H]{.ul}~2~, 29-C[H]{.ul}~2~), 4.29 (d, 1H, *J* = 5 Hz, 2-C[H]{.ul}), 2.38 (s, 3H, 25-C[H~3~]{.ul}); ^13^C-NMR (CDCl~3~) δ (ppm): 167.9 (20-[C]{.ul}), 166.4 (1-[C]{.ul}), 164.8 (3-[C]{.ul}), 150.0 (10-[C]{.ul}), 143.2 (13-[C]{.ul}), 139.5 (22-[C]{.ul}), 134.8 (30-[C]{.ul}), 132.0 (36-[C]{.ul}), 131.1 (23-[C]{.ul}), 131.1 (32-[C]{.ul}), 128.7 (34-[C]{.ul}), 128.7 (38-[C]{.ul}), 128.6 (40-[C]{.ul}), 128.6 (12-[C]{.ul}), 128.5 (31-[C]{.ul}), 128.5 (35-[C]{.ul}), 128.2 (37-[C]{.ul}), 128.2 (41-[C]{.ul}), 128.1 (39-[C]{.ul}), 128.1 (33-[C]{.ul}), 127.2 (15-[C]{.ul}), 127.2 (26-[C]{.ul}), 124.7 (25-[C]{.ul}), 123.1 (16-[C]{.ul}), 121.4 (24-[C]{.ul}), 121.0 (17-[C]{.ul}), 119.3 (27-[C]{.ul}), 111.3 (14-[C]{.ul}), 104.7 (11-[C]{.ul}), 68.7 (28-[C]{.ul}), 67.9 (29-[C]{.ul}), 57.2 (8-[C]{.ul}), 54.3 (2-[C]{.ul}), 21.4 (25-[C]{.ul}); MS (ESI): *m/z* = 593 \[M+H\]^+^, 615 \[M+Na\]^+^; MS (HREI): C~34~H~28~N~2~O~4~S~2~ Na for +, calculated 592.1490, found 592.1491; IR (KBr, cm^−1^) ν 3346, 2954, 1743, 1724, 1533, 1481, 1255, 1188, 812, 744.

*(+) Dibenzyl 2-(benzo\[b\]thiophen-2-yl((6-methylbenzo\[d\]thiazol-2-yl)amino)methyl) malonate* (**5pc**). This product was obtained as a white solid from a reaction catalyzed by **Q** (10 mol%) at 25 °C for 96 h; mp: 126--128 °C; yield: 79% after column chromatography purification (silica gel, PE/ethyl ether = 7/1); 86.0% ee as determined by HPLC \[Daicel Chiralpak IA, hexane/EtOH = 75/25, 1.0 mL/min, λ = 254 nm, tr (major) = 12.63 min, tr (minor) = 17.04 min\]; ![](molecules-19-03955-i003.jpg) = +168.96 (c = 0.029 g/100 mL, CHCl~3~).

3.3. Antifungal Activity Section
--------------------------------

The antifungal activity of all synthesized compounds was tested against six pathogenic fungi, *G*. *azeae*, *F*. *oxysporum*, *C*. *mandshurica*, *P*. *sasakii*, *P*. *infestans and S*. *sclerotiorum* through the poison plate technique. All the compounds were dissolved in dimethyl sulfoxide (DMSO, 10 mL) before mixing with potato dextrose agar (PDA, 90 mL). The compounds were tested at a concentration of 50 μg/mL. All fungal species were incubated in PDA at 27 ± 1 °C for 5 day to obtain new mycelium for antifungal assay. Mycelia dishes approximately 4 mm in diameter were cut from the culture medium. One of the specimens was picked up with a sterilized inoculation needle and then inoculated in the center of the PDA plate aseptically. The inoculated plates were incubated at 27 ± 1°C for 5 day. DMSO in sterile distilled water served as the control, whereas hymexazole acted as the positive control. Three replicates were conducted for each treatment. The radial growth of the fungal colonies was measured, and the data were statistically analyzed. The inhibitory effects of the test compounds *in vitro* against these fungi were calculated as follows: where C represents the diameter of fungal growth on untreated PDA, T represents the diameter of fungi on treated PDA, and I is the inhibitory rate.

4. Conclusions
==============

Sixteen pairs of chiral β-amino acid ester derivatives containing benzothiophene and benzothiazole units were designed and synthesized. The desired products **5a**--**p** were obtained in good yields and high enantioselectivities (\~86% yield, \>99% ee) according to the optimized reaction conditions. The enantioselectivity of **5dc**, **5hc**, **5lc** and **5pc** was higher than the other compounds, probably because the malonate ester was a benzyl ester, and steric hindrance affected the Mannich-type reaction between the imines and benzyl esters. Bioassays identified these new compounds as possessing weak to good antifungal activity. The inhibition rate of **5dr** against *F*. *oxysporum* was 60.53%, higher than the commercial agricultural fungicide hymexazole whose inhibition rate was 56.12% at a concentration of 50 μg/mL. Further experimental studies of the mechanism of antifungal activity are underway.
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